Delivery Order SPE2DB22D3301-SPE2DB25FX9PR
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$72K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Otezla 30 mg tablets (60 count) to the Defense Logistics Agency (DLA), a major logistics agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distribution company, for a ceiling value of $34,985.94 over the contract period ending on April 24, 2024. This is a firm-fixed price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $10,633.20, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $8,119.86, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of July 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Otezla 30 mg tablets in quantities of 60 to the Defense Logistics Agency (DLA). The $35,497.88 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract has an ultimate completion date of January 4, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $19,781.52 and a period of performance through August 17, 2023. It is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen holds a larger...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,379.24 and a performance period through March 15, 2023. The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,330.58, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 30, 2022 with a completion date of March 31, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $29,847.48 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., as a delivery order under their $999,999,999 Indefinite Delivery Contract (IDC) with the DLA. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $4,505.32. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of September 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds...
This federal contract award is for the delivery of Otezla 30mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $27,230.48 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 22, 2024, with a period of performance through October 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...